Elad Shemesh

Clinician-Scientist focusing on lipid disorders and genetics of CVD. McMaster University / Population Health Research Institute, Canada.

[Elad Shemesh @Elad_md]

@Mark_AbelaMD @escardio @ESC_Journals Wow! congrats!

[Elad Shemesh @Elad_md]

@paragchevli @WFCardiology @DrMichaelShapir Congratulations! Way to go 🎖️

[J.K. Rowling @jk_rowling]

Kidnapping children is despicable and wholly unjustifiable. For obvious reasons, this picture has hit home with me. May Noya and all hostages taken by Hamas be returned soon, safely, to their families.

[Elad Shemesh @Elad_md]

@jewuner אוהד ותיק , סיימתי איתם. לא אתמוך בהם יותר.

[Elad Shemesh @Elad_md]

@JewishGooners @ben_rumsby @David_Ornstein @johncrossmirror @JewishGooners meanwhile, Elneni changes his profile picture to sympathize with terrorist crimes and the club remains silent

[Elad Shemesh @Elad_md]

@jewuner @sheziff פיד כדורגל

[Elad Shemesh @Elad_md]

@AidaTuma @sheziff אתה יכול להסביר לה מה קורה אחרי שריקת המחצית ?

[Elad Shemesh @Elad_md]

🚨CVD Prevention in Europe: Find out What Has Changed in Your Country 🌍🚨

Our latest manuscript exploring trends in CVD prevention strategies in Europe 📜🔍
@AbrahamSBabu @Mark_AbelaMD @SalzwedelAnnett @ESC_Journals @escardio
🔗https://t.co/XYnPDbMlUG

[Elad Shemesh @Elad_md]

Delighted to receive the best poster award at the Israel Endocrine meeting for our work on Cardiac biomarkers in Fabry disease. Massive thanks for the support from
@escardio @IsraelAcademy @acmedsci

#Fabry #CardioTwitter

[Parag Chevli MD MS @paragchevli]

Our latest article on circulating #ketonebodies and #CVD is published in EHJ's latest issue. Thank you @ehj_ed for selecting it as an "Editor's Choice" article.
https://t.co/0KRWD4FXmf
@ESC_Journals #EHJ
@Elad_md @mvaduganathan @DrMichaelShapir @wakehealthHM @wakeforestmed

[Elad Shemesh @Elad_md]

Really proud and humbled to be part of this list and to have the opportunity to learn something new from each manuscript. Thanks @DiabetesCareADA for the ongoing trust
https://t.co/l7tPDPEutf

[Elad Shemesh @Elad_md]

@maciejbanach @DrPenson @GaniBajraktari @BytyciIbadete @myhenein @MichaelJBlaha @MoMaz20 @afgcicero @FedericaFogacci @suzjudd @fahadalnouri Hi. Definitely interested! Can contribute based on my previous experience (formal training and publications) with Cochrane

[Alfonso Valle @ValleAlfonso]

Circulating ketone bodies (KB) as signals for CV disease and mortality

👉 KBs could serve as a biomarker for new-onset HF
👉↗️circulating levels of KBs can be predictive for other CVDs
👉association is independent of sex and ethnicity

📥 https://t.co/iSiSAxxFx8

[Muthu Vaduganathan @mvaduganathan]

Fascinating work now out in @escardio #EHJ by @Elad_md & @paragchevli from #MESA study

Even though *exogenous* #KetoneBodies may have salutary effects in CV disease, circulating *endogenous* #KetoneBodies appear to be associated with adverse CV outcomes.

https://t.co/FUFYW6DIUz

[Abraham Samuel Babu @AbrahamSBabu]

Excited to see this report led by Nicolle Krankel & Annett Salzwedel from #EAPC @escardio @EAPCPresident on #implementation of #CVD #prevention programs in #Europe. Link to full report https://t.co/LSVZIHs2w6
A great experience working with #EAPCYoung ambassadors on this report!

[Elad Shemesh @Elad_md]

🚀#ESCPrev2022 is approaching! 7-9th April.
The program is packed with some great #cvprevention science
🚩Make sure to attend poster session 1- Primary Care and Risk Factor Management, which I'll be chairing
@escardio @EAPCPresident @MichaelPapadak2

[Elad Shemesh @Elad_md]

2 years & a world pandemic later, but finally back in Cambridge to continue my research

[Elad Shemesh @Elad_md]

@BarteltLab @JoergHeeren @UKEHamburg @ghotamis @MET_HSPH @ChusaGzlzRellan @tugraz @UniGraz @MedUniGraz @NAWIGraz @bacterialmaster @LMU_Uniklinikum @LMU_Muenchen @ipekresearch @helmholtz_diabc @ERC_Research Inspiring and helpful! Thanks for sharing